SGMO logo

Sangamo Therapeutics (SGMO) Short Term Debt

Annual Short Term Debt

$4.59 M
+$467.00 K+11.33%

31 December 2023

SGMO Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Short Term Debt

N/A

30 September 2024

SGMO Quarterly Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SGMO Short Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+11.3%-
3 y3 years+24.4%-
5 y5 years+100.0%-

SGMO Short Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+24.4%
5 y5 yearsat high
alltimeall timeat high

Sangamo Therapeutics Short Term Debt History

DateAnnualQuarterly
Dec 2023
$4.59 M(+11.3%)
$4.59 M(+11.3%)
Dec 2022
$4.12 M(+2.4%)
$4.12 M(+2.4%)
Dec 2021
$4.03 M(+9.1%)
$4.03 M(+9.1%)
Dec 2020
$3.69 M(+14.8%)
$3.69 M(+14.8%)
DateAnnualQuarterly
Dec 2019
$3.21 M(>+9900.0%)
$3.21 M(>+9900.0%)
Dec 2018
$0.00(-100.0%)
$0.00(-100.0%)
June 2002
-
$234.00 K(-56.3%)
Mar 2002
-
$536.00 K(+88.1%)
Dec 2001
$285.00 K
$285.00 K

FAQ

  • What is Sangamo Therapeutics annual short term debt?
  • What is the all time high annual short term debt for Sangamo Therapeutics?
  • What is Sangamo Therapeutics annual short term debt year-on-year change?
  • What is the all time high quarterly short term debt for Sangamo Therapeutics?

What is Sangamo Therapeutics annual short term debt?

The current annual short term debt of SGMO is $4.59 M

What is the all time high annual short term debt for Sangamo Therapeutics?

Sangamo Therapeutics all-time high annual short term debt is $4.59 M

What is Sangamo Therapeutics annual short term debt year-on-year change?

Over the past year, SGMO annual short term debt has changed by +$467.00 K (+11.33%)

What is the all time high quarterly short term debt for Sangamo Therapeutics?

Sangamo Therapeutics all-time high quarterly short term debt is $4.59 M